Showing results (151-160 of 157) with videos related to
Sort By:
Pageof 16
You have reached the last page of results.This site can display upto 157 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 11, 2019
Class 1, 2, and 3 <i>BRAF</i>-Mutated Metastatic Colorectal Cancer: A Detailed Clinical, Pathologic, and Molecular CharacterizationMarta Schirripa, Paola Biason, Sara Lonardi, et al.Journal of Experimental & Clinical Cancer Research : CR|January 14, 2025
Targeting of the G9a, DNMT1 and UHRF1 epigenetic complex as an effective strategy against pancreatic ductal adenocarcinomaDaniel Oyon, Amaya Lopez-Pascual, Borja Castello-Uribe, et al.BJU International|June 10, 2026
Delphi consensus on ex vivo fluorescence confocal microscopy in robot-assisted radical prostatectomyEdoardo Beatrici, Mario de Angelis, Ricardo Almeida-Magana, et al.Journal of Crohn'S & Colitis|March 24, 2017
Small Bowel Carcinomas in Coeliac or Crohn's Disease: Clinico-pathological, Molecular, and Prognostic Features. A Study From the Small Bowel Cancer Italian ConsortiumAlessandro Vanoli, Antonio Di Sabatino, Daniela Furlan, et al.Annals of Surgical Oncology|August 8, 2020
Prognostic Role of Mismatch Repair Status, Histotype and High-Risk Pathologic Features in Stage II Small Bowel AdenocarcinomasAlessandro Vanoli, Federica Grillo, Camilla Guerini, et al.Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 19, 2020
PD-L1 in small bowel adenocarcinoma is associated with etiology and tumor-infiltrating lymphocytes, in addition to microsatellite instabilityPaolo Giuffrida, Giovanni Arpa, Federica Grillo, et al.Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|March 6, 2020
Correction: PD-L1 in small bowel adenocarcinoma is associated with etiology and tumor-infiltrating lymphocytes, in addition to microsatellite instabilityPaolo Giuffrida, Giovanni Arpa, Federica Grillo, et al.Pageof 16